Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Candor Rx vs Eve

Candor Rx
Graded #60

Higher grade

vs+8.5
Eve
Graded #189

Lower grade

The verdict

Candor Rx takes it — 74.8/100 to 66.3/100.

Candor Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Candor Rx (candorrx.com) is a GLP-1 telehealth service offering compounded semaglutide and tirzepatide with flat, dose-independent pricing marketed as '$95/month, any dose, forever.' Semaglutide starts as…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCandor Rx +41
96
55
Dose & formulationEve +16
72
88
Clinical oversightEve +3
76
79
Labs & monitoringEven
52
52
FulfillmentCandor Rx +4
71
67
Contract termsCandor Rx +20
61
41
Candor Rx · left barEve · right bar

The numbers

MetricCandor RxEve
WeighScore74.8/10066.3/100
GradeCC
Scorecard rank#60#189
Semaglutide$99/mo (all doses, compounded)$195/mo (compounded)
Tirzepatide$149/mo (all doses, compounded)$195/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Candor Rx

Graded #60 · C

Strengths

  • Flat, dose-independent pricing marketed as '$95/month, any dose, forever' — no upcharge as your dose increases
  • Low starting prices: compounded semaglutide as low as $99/mo and tirzepatide as low as $149/mo
  • Medication ships in about 48 hours and you can cancel anytime
  • Simple, transparent GLP-1 focus with pricing shown up front before signup

Where it loses points

  • Prescribing medical group and compounding pharmacy are not named on the site
  • States of operation are not published; confirm eligibility during intake
  • No LegitScript certification is displayed
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Eve

Graded #189 · C

Strengths

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • LegitScript Certified with a verifiable ID
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

Where it loses points

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard